Annual report
3407.TEDINET S100W2HS
Period2024-04-01 → 2025-03-31
Filed2025-06-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥3.04T | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥2.78T | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥2.73T | 2022-04-01 → 2023-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.46T | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.11T | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥211.9bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥140.7bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥193.5bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥90.1bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥120.9bn | 2022-04-01 → 2023-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥212.1bn | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥178.0bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥194.6bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥28.8bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥135.0bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥43.8bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥91.9bn | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥161.9bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥79.8bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥140.4bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥46.3bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥4.02T | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥3.66T | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥3.45T | at 2023-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥3.35T | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥2.92T | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.10T | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥1.81T | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.91T | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.85T | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.70T | at 2023-03-31d | Cons. | Net assets |
| Net assets / equity | ¥1.72T | at 2022-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥1.49T | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥393.5bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥338.1bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥390.0bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥333.5bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥247.9bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥242.9bn | at 2022-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥216.2bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥301.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥295.3bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥90.8bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥183.3bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥253.7bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥381.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥142.6bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥213.6bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥221.0bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥157.8bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥144.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥94.3bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥111.8bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥42.3bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥95.9bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥97.94 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥31.6 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-66.3 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥116.68 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥57.49 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥1,369.16 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,308.2 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,197.85 | at 2023-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,216.33 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,057.61 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 46.3% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.5% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.1% | at 2023-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.4% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.3% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 7.4% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 2.5% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | -5.5% | 2022-04-01 → 2023-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.3% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.6% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 50,352 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 49,295 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 48,897 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 46,751 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 44,497 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥726.5bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥681.5bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥714.0bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥652.6bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥548.1bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥650m | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | −¥26.5bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥16.3bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥192.6bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥38.9bn | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥81.9bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥64.5bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥21.8bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥102.1bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥37.0bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥170.2bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | −¥201.4bn | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥52.5bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥67.7bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥2.18T | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥1.97T | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥2.00T | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.15T | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.29T | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.61T | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥1.34T | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥566.5bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥625.6bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥506.8bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥771.8bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥790.3bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥43.0bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥44.4bn | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥26.86 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥122.76 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-145.24 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.83 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥48.8 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥38 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥36 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥36 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥34 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥34 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥417.12 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥451.32 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥365.62 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥556.34 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥569.58 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 26.0% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.8% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.4% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.9% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.5% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 6.2% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 30.1% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -31.5% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.7% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.8% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,365,752,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,393,932,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,393,932,000 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,393,932,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,393,932,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 8,288 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 8,810 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 8,787 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 8,646 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 8,524 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 89
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2024-04-01 → 2025-03-31 | ¥1.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2024-04-01 → 2025-03-31 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2025-03-31 | 1366 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2025-03-31 | ¥62.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2025-03-31 | ¥16.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥45.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2025-03-31 | ¥123.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2025-03-31 | ¥2.9bn |
| Health Carereportable segment | capex | 2024-04-01 → 2025-03-31 | ¥42.6bn |
| Health Carereportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥54.7bn |
| Health Carereportable segment | employees | at 2025-03-31 | 11961 pure |
| Health Carereportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥615.9bn |
| Health Carereportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥615.9bn |
| Health Carereportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥5m |
| Health Carereportable segment | segment assets | at 2025-03-31 | ¥1.33T |
| Health Carereportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥64.0bn |
| Homesreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥31.5bn |
| Homesreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥20.7bn |
| Homesreportable segment | employees | at 2025-03-31 | 13308 pure |
| Homesreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥1.05T |
| Homesreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥1.04T |
| Homesreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥10.0bn |
| Homesreportable segment | segment assets | at 2025-03-31 | ¥688.1bn |
| Homesreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥95.9bn |
| Materialreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥124.2bn |
| Materialreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥64.1bn |
| Materialreportable segment | employees | at 2025-03-31 | 20709 pure |
| Materialreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥1.39T |
| Materialreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥1.37T |
| Materialreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥18.2bn |
| Materialreportable segment | segment assets | at 2025-03-31 | ¥1.83T |
| Materialreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥87.4bn |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥198.4bn |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥139.5bn |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥3.05T |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥3.02T |
| —segment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥28.3bn |
| —segment total | segment assets | at 2025-03-31 | ¥3.85T |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥247.3bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-04-01 → 2025-03-31 | ¥200.1bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-04-01 → 2025-03-31 | ¥140.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2025-03-31 | ¥3.11T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2025-03-31 | ¥3.04T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥73.8bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-03-31 | ¥3.97T |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2025-03-31 | ¥250.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2023-04-01 → 2024-03-31 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2023-04-01 → 2024-03-31 | ¥926m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2024-03-31 | ¥56.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2024-03-31 | ¥15.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥41.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2024-03-31 | ¥128.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2024-03-31 | ¥3.2bn |
| Health Carereportable segment | capex | 2023-04-01 → 2024-03-31 | ¥32.2bn |
| Health Carereportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥47.2bn |
| Health Carereportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥553.8bn |
| Health Carereportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥553.8bn |
| Health Carereportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥4m |
| Health Carereportable segment | segment assets | at 2024-03-31 | ¥1.05T |
| Health Carereportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥48.5bn |
| Homesreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥25.8bn |
| Homesreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥20.1bn |
| Homesreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥964.0bn |
| Homesreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥954.4bn |
| Homesreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥9.6bn |
| Homesreportable segment | segment assets | at 2024-03-31 | ¥609.4bn |
| Homesreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥83.0bn |
| Materialreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥111.5bn |
| Materialreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥72.0bn |
| Materialreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥1.27T |
| Materialreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥1.26T |
| Materialreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥12.3bn |
| Materialreportable segment | segment assets | at 2024-03-31 | ¥1.76T |
| Materialreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥42.6bn |
| —segment total | capex | 2023-04-01 → 2024-03-31 | ¥169.4bn |
| —segment total | depreciation | 2023-04-01 → 2024-03-31 | ¥139.3bn |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥2.79T |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥2.77T |
| —segment total | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥21.9bn |
| —segment total | segment assets | at 2024-03-31 | ¥3.42T |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | ¥174.0bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-04-01 → 2024-03-31 | ¥170.6bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-04-01 → 2024-03-31 | ¥140.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2024-03-31 | ¥2.85T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2024-03-31 | ¥2.78T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥63.1bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-03-31 | ¥3.55T |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2024-03-31 | ¥177.2bn |
| Materialreportable segment | employees | at 2025-03-31 | 5280 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 2,150
| Item | Context | Value | Unit |
|---|---|---|---|
| Regular employees differences in wages between male and female employees metrics of consolidated subsidiaries | CurrentYearInstant_Row13Member | 0.900 | |
| Non regular employees differences in wages between male and female employees metrics of consolidated subsidiaries | CurrentYearInstant_Row13Member | 0.733 | |
| Ratio of female employees in managerial positions metrics of consolidated subsidiaries | CurrentYearInstant_Row14Member | 0.036 | |
| All employees ratio of male employees taking childcare leave metrics of consolidated subsidiaries | CurrentYearInstant_Row14Member | 0.620 | |
| All employees differences in wages between male and female employees metrics of consolidated subsidiaries | CurrentYearInstant_Row14Member | 0.758 | |
| Regular employees differences in wages between male and female employees metrics of consolidated subsidiaries | CurrentYearInstant_Row14Member | 0.801 | |
| Non regular employees differences in wages between male and female employees metrics of consolidated subsidiaries | CurrentYearInstant_Row14Member | 0.625 | |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E00877-000MaterialReportableSegmentsMember | 43511000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E00877-000HomesReportableSegmentsMember | 3814000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E00877-000HealthCareReportableSegmentsMember | 52247000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_OtherOperatingSegmentsAxisMember | 137000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration | 110641000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E00877-000MaterialReportableSegmentsMember | 124223000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E00877-000HomesReportableSegmentsMember | 31493000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E00877-000HealthCareReportableSegmentsMember | 42644000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 1787000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_ReportableSegmentsMember | 200147000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_UnallocatedAmountsAndEliminationMember | 10879000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 211026000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 1365751932 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 1365751932 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 1365751932 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 1365751932 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 165 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 45 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 1237 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 828 | |
| Number of shareholders foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 579 | |
| Number of shareholders individuals and others | CurrentYearInstant_OrdinaryShareMember | 165655 | |
| Number of shareholders total | CurrentYearInstant_OrdinaryShareMember | 168509 | |
| Number of shares held number of units national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shares held number of units financial institutions | CurrentYearInstant_OrdinaryShareMember | 5291018 | |
| Number of shares held number of units financial service providers | CurrentYearInstant_OrdinaryShareMember | 647120 | |
| Number of shares held number of units other corporations | CurrentYearInstant_OrdinaryShareMember | 329364 | |
| Number of shares held number of units foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 4803588 | |
| Number of shares held number of units foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 2901 | |
| Number of shares held number of units individuals and others | CurrentYearInstant_OrdinaryShareMember | 2569077 | |
| Number of shares held number of units total | CurrentYearInstant_OrdinaryShareMember | 13643068 | |
| Number of shares held shares less than one unit | CurrentYearInstant_OrdinaryShareMember | 1445132 | |
| Percentage of shareholdings national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Percentage of shareholdings financial institutions | CurrentYearInstant_OrdinaryShareMember | 0.3878 | |
| Percentage of shareholdings financial service providers | CurrentYearInstant_OrdinaryShareMember | 0.0474 | |
| Percentage of shareholdings other corporations | CurrentYearInstant_OrdinaryShareMember | 0.0241 | |
| Percentage of shareholdings foreigners other than individuals | CurrentYearInstant_OrdinaryShareMember | 0.3521 | |
| Percentage of shareholdings foreign individuals | CurrentYearInstant_OrdinaryShareMember | 0.0002 | |
| Percentage of shareholdings individuals and others | CurrentYearInstant_OrdinaryShareMember | 0.1883 | |
| Number of shares held | CurrentYearInstant_No1MajorShareholdersMember | 224915000 | |
| Shareholding ratio | CurrentYearInstant_No1MajorShareholdersMember | 0.1654 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |